| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9369679 | Archives de Pédiatrie | 2005 | 5 Pages |
Abstract
Halofantrine and mefloquine are efficient for falciparum malaria treatment in our pediatric series, despite a high rate of adverse events. Mefloquine's tolerance may probably be improved with changes in regimen and dose. Relapses are more frequent with a single first treatment of halofantrine, than with mefloquine. Unfortunately, features of a second halofantrine treatment are not defined.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
P. Minodier, G. Noël, M. Salles, K. Retornaz, H. Walters, J.C. Combes, J.M. Garnier,